Abeona Therapeutics Inc. Financial Ratios — ABEO Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	-40.05	-26.22	-20.3	-37.27	-48.82	-59.96	-117.22	-125.79	-260.6	-216.57	70.05
Return on Assets (%)	-40.33	-381.94	379.77	-311.46	-30.06	-22.89	-18.85	-32.09	-38.35	-44.98	-73.61	-55.21	-84.53	-73.71	43.34
Return on Capital (%)	- -	- -	-29.68	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	59.63
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-71.06
Gross Margin (%)	91.95	93.94	93.88	100	100	100	100	100	- -	100	100	68.18	54.14	- -	41.15
EBITDA Margin (%)	-415.61	-88.49	-186.14	-337.3	-1,730.29	-2,593.48	-3,237.16	-1,861.44	- -	-429.03	-1,763.53	-2,876.94	-1,285.77	- -	-1,475.69
Operating Margin (%)	-428.28	-98	-186.29	-338.49	-1,783.27	-2,686.28	-3,325.69	-1,940.16	- -	-485.04	-1,912.33	-3,200.64	-1,377.14	- -	-1,536.91
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	631.22	- -	- -	- -	- -	457.46	- -
Pretax Margin (%)	-136.76	-239.15	217.87	-2,894.92	-1,396.73	-2,460.4	-3,263.92	-1,890.29	- -	-842.34	-2,831.2	-2,807.36	-1,548.23	- -	1,224.79
Profit Margin (%)	-137.68	-239.15	217.87	-2,894.92	-1,396.73	-2,460.4	-3,263.92	-1,890.29	- -	-842.34	-2,831.2	-2,807.36	-1,548.23	- -	1,223.08
Net Income to Common Margin (%)	-234.15	-284.54	75.95	-3,205.73	-1,396.73	-2,460.4	-3,263.92	-1,890.29	- -	-842.34	-2,831.2	-3,074.82	-1,548.23	- -	1,223.08
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.14
Dvd Payout Ratio (%)	41.2	15.95	-186.85	9.7	- -	- -	- -	- -	- -	- -	- -	8.7	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	-40.05	-26.22	-20.3	-37.27	-48.82	-59.96	-117.22	-114.85	-260.6	-216.57	70.05

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	3	- -	- -	4	4	- -	- -	10	8	9	9	8	5	23	25
ST Debt	3	- -	- -	- -	- -	- -	- -	10	2	2	2	2	1	7	13
LT Debt	- -	- -	- -	4	4	- -	- -	- -	6	7	8	6	4	16	12
Total Debt/EBITDA	-0.36	- -	- -	-1.41	-0.22	- -	- -	-0.18	-0.12	-0.2	-0.18	-0.19	-0.12	-0.38	-0.29
Net Debt/EBITDA	-0.04	0.1	0.11	2.28	2.01	3	5.08	-0.2	1.89	0.25	0.62	0.35	0.32	0.07	0.68
Total Debt/EBIT	-0.35	- -	- -	-1.41	-0.22	- -	- -	-0.17	-0.1	-0.18	-0.16	-0.17	-0.11	-0.36	-0.28
Net Debt/EBIT	-0.04	0.09	0.11	2.27	1.95	2.9	4.95	-0.19	1.68	0.22	0.57	0.31	0.3	0.07	0.65
EBITDA to Interest Expense	- -	-6.41	-13.62	-5.36	-2,999.17	-3,842.67	-3,386.88	-5,073.27	-171.03	-10.43	-14.47	-55.27	-107.66	-14.57	-22.96
EBITDA-CapEx/Interest Expense	- -	-6.41	-13.62	-5.36	-2,999.17	-3,842.67	-3,386.88	-6,005.18	-171.53	-10.43	-14.47	-55.27	-107.66	-14.57	-22.96
EBIT to Interest Expense	- -	-7.1	-13.63	-5.38	-3,091	-3,980.17	-3,479.5	-5,287.82	-192.72	-11.79	-15.69	-61.49	-115.31	-15.26	-23.92
Interest Expense	- -	1	- -	1	- -	- -	- -	- -	- -	4	4	1	- -	4	4
Common Equity/Total Assets	-465.15	-987.05	-2,410.93	29.04	84.59	89.23	95.15	76.86	79.88	67.83	53.24	41.67	23.16	40.42	72.51
Long-Term Debt/Equity (%)	- -	- -	- -	83.06	5.91	- -	- -	- -	3.5	6.52	17.84	21.88	29.69	37.02	7.46
Long-Term Debt/Capital (%)	- -	- -	- -	43.4	5.58	- -	- -	- -	3.35	6.01	14.61	17.02	21.76	24.3	6.45
Long-Term Debt/Total Assets (%)	- -	- -	- -	24.12	5	- -	- -	- -	2.8	4.42	9.5	9.12	6.88	14.96	5.41
Total Debt/Equity (%)	-15.62	- -	- -	91.36	5.91	- -	- -	7.46	4.46	8.51	22.13	28.5	36.42	52.34	15.68
Total Debt/Capital (%)	-18.51	- -	- -	47.74	5.58	- -	- -	6.94	4.27	7.85	18.12	22.18	26.7	34.36	13.56
Total Debt/Total Assets (%)	72.66	- -	- -	26.53	5	- -	- -	5.73	3.56	5.77	11.78	11.88	8.44	21.16	11.37
Net Debt to Equity	-1.65	2.32	2.87	-147.84	-53.36	-69.77	-80.98	8.39	-72.44	-10.57	-77.74	-53.13	-97.62	-9.98	-36.68
Net Debt/Capital (%)	-1.67	2.27	2.79	309.03	-114.42	-230.81	-425.84	8.98	-226.28	-10.98	-175.13	-70.48	-251.57	-10.05	-55.23
EBITDA	-8	-4	-4	-3	-18	-23	-27	-56	-68	-43	-53	-41	-45	-61	-86
EBITDA-CapEx	-8	-4	-4	-3	-18	-23	-27	-66	-69	-43	-53	-41	-45	-61	-86
Operating Income (Loss)	-8	-4	-4	-3	-19	-24	-28	-58	-77	-49	-57	-45	-48	-64	-89

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.2	0.06	0.05	3.98	27.18	8.33	24.57	4.17	3.34	2.26	2.71	6.7	3.89	5.89	6.47
Current Ratio	0.27	0.25	0.06	3.99	27.47	8.37	25.07	4.37	3.42	2.33	3.39	6.83	4.15	6.08	6.93
Quick Ratio	0.23	0.19	0.06	3.99	27.25	8.35	24.59	4.18	3.34	2.26	2.89	6.73	4.07	5.99	6.7
CFO/Avg Current Liab	-0.58	-0.42	- -	-0.27	-4.76	-2.66	-3.26	-3.01	-2.13	-0.87	-2.24	-3.56	-3.49	-3.73	-3.31
Common Equity/Total Assets	-465.15	-987.05	-2,410.93	29.04	84.59	89.23	95.15	76.86	79.88	67.83	53.24	41.67	23.16	40.42	72.51
Long-Term Debt/Equity (%)	- -	- -	- -	83.06	5.91	- -	- -	- -	3.5	6.52	17.84	21.88	29.69	37.02	7.46
Long-Term Debt/Capital (%)	- -	- -	- -	43.4	5.58	- -	- -	- -	3.35	6.01	14.61	17.02	21.76	24.3	6.45
Long-Term Debt/Total Assets (%)	- -	- -	- -	24.12	5	- -	- -	- -	2.8	4.42	9.5	9.12	6.88	14.96	5.41
Total Debt/Equity (%)	-15.62	- -	- -	91.36	5.91	- -	- -	7.46	4.46	8.51	22.13	28.5	36.42	52.34	15.68
Total Debt/Capital (%)	-18.51	- -	- -	47.74	5.58	- -	- -	6.94	4.27	7.85	18.12	22.18	26.7	34.36	13.56
Total Debt/Total Assets (%)	72.66	- -	- -	26.53	5	- -	- -	5.73	3.56	5.77	11.78	11.88	8.44	21.16	11.37
CFO/Total Liabilities	-35.57	-21.03	0.01	-13.69	-84.51	-108.81	-261.36	-96.92	-139.75	-71.99	-176.43	-116.1	-75.26	-86.31	-126.46
CFO/CapEx	- -	- -	- -	- -	- -	- -	- -	-3.82	-315.68	- -	- -	- -	- -	- -	- -
Altman's Z-Score	-113.68	-225.79	-641.78	-32.16	-5.58	3.1	48.4	-1.8	-1.67	-5.66	-12.7	-15.74	-16.41	-9.12	-2.21

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	11.05	7.51	4.47	16.97	13.87	7.44	7.25	31.89	- -	- -	2	0.94	- -	- -	1.89
Days Sales Outstanding	33.05	48.61	81.69	21.51	26.32	49.06	50.37	11.44	- -	- -	182.5	387.2	- -	- -	192.75
Inventory Turnover	1.96	1.55	1.29	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.25
Days Inventory Outstanding	186.2	235.81	283.24	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	292.69
Accounts Payable Turnover	0.13	0.17	-0.05	- -	- -	- -	- -	- -	- -	- -	- -	0.15	0.87	- -	1.57
Accounts Payable Turnover Days	2,866.9	2,208.84	-7,675.58	- -	- -	- -	- -	- -	- -	- -	- -	2,488.49	417.19	- -	231.86
Cash Conversion Cycle	-2,647.65	-1,924.42	8,040.51	- -	- -	- -	- -	- -	- -	- -	- -	-2,101.29	-417.19	- -	253.59
Inventory to Cash Days	-153.15	-187.21	-201.55	- -	- -	- -	- -	- -	- -	- -	- -	387.2	- -	- -	-99.94
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	34	6	6	69	110	195	743	342	273	151	50	55	133	254	290
- Cash & Cash Equivalents	2	- -	- -	12	40	69	138	19	129	13	33	14	14	23	78
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	3	- -	- -	4	4	- -	- -	10	8	9	9	8	5	23	25
Enterprise Value	35	6	6	62	74	126	605	267	152	65	14	10	86	180	124
Total Capital	-15	-17	-15	9	72	99	170	144	186	111	52	34	20	67	184
Total Debt/Capital (%)	-18.51	- -	- -	47.74	5.58	- -	- -	6.94	4.27	7.85	18.12	22.18	26.7	34.36	13.56
Total Debt / EV	0.08	- -	- -	0.07	0.05	- -	- -	0.04	0.05	0.14	0.65	0.76	0.06	0.13	0.2
EV/Sales	18.86	1.26	2.94	66.75	71.04	141.84	723.33	89.18	- -	6.46	4.8	7.11	24.59	- -	21.24
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	21.46	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	21.46	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	29	6	6	7	93	166	660	339	165	145	33	24	107	229	349
Diluted Enterprise Value	29	5	6	- -	57	97	522	331	43	142	10	18	98	228	295
EV per Share	1,815.17	279.98	291.9	77.33	56.41	78.31	322.8	139.41	45.48	16.81	2.45	0.57	3.24	3.93	2.25
TTM Sales	2	4	2	1	1	1	1	3	- -	10	3	1	4	- -	6
TTM EBITDA	-8	-4	-4	-3	-18	-23	-27	-56	-68	-43	-53	-41	-45	-61	-86
TTM Operating Income	-8	-4	-4	-3	-19	-24	-28	-58	-77	-49	-57	-45	-48	-64	-89
TTM Cash Flow to Firm	-8	-3	- -	-1	-10	-13	-23	-39	-62	-31	-62	-43	-37	-52	-73
TTM Free Cash Flow to Firm	-8	-3	- -	-1	-10	-13	-23	-29	-62	-31	-62	-43	-37	-52	-73

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-3.78	-1.47	6,368.12	-4.16	-8.9	-12.74	-29.13	-11.76	-2.63	-4.15	-0.51	-0.56	-2.89	-4.08	-4.57
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	35	6	6	62	74	126	605	267	152	65	14	10	86	180	124
Low Price	1,450	262.5	262.5	82.5	68.75	51.25	112.5	156.5	36.5	24.75	6.75	2.34	2.19	3.05	3.93
EV/Sales	18.86	1.26	2.94	66.75	71.04	141.84	723.33	89.18	- -	6.46	4.8	7.11	24.59	- -	21.24
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	4.07	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.92
Price/Earnings Average	-9.33	-1.45	6.65	-1.04	-8.83	-6.09	-14.47	-11.59	-3.22	-2.56	-1.68	-0.89	-1.41	-3.67	4.19
Price/Earnings High	-12.07	-2.78	13.02	-1.97	-21.18	-14.75	-34.67	-18.45	-5.55	-4.77	-4.39	-1.76	-2.13	-5.8	5.61
Price/Earnings Low	-5.38	-0.41	3.42	-0.22	-5.22	-3.2	-6.86	-5.25	-0.96	-1.09	-0.31	-0.42	-0.86	-1.96	2.92
Price/Book Value	-1.95	-0.35	-0.44	14.3	1.62	1.97	4.37	2.55	1.53	1.47	1.18	2.04	8.96	5.77	1.82
Price/Book Value Average	-2.73	-1.09	-0.71	65.71	2.25	1.58	2.62	4.94	2.29	2.18	5.05	3.27	6.4	5.91	1.95
Price/Book Value High	-3.53	-2.09	-1.39	124.34	5.39	3.83	6.27	7.87	3.94	4.07	13.17	6.46	9.66	9.34	2.61
Price/Book Value Low	-1.57	-0.3	-0.37	13.68	1.33	0.83	1.24	2.24	0.68	0.93	0.94	1.55	3.92	3.16	1.36
Price/Tangible Book Value	-1.91	-0.35	-0.44	-393.51	3.84	3.35	5.56	5.85	2.49	2.2	1.22	2.04	8.96	5.77	1.82
Price/Tangible Book Value Average	-2.67	-1.09	-0.71	-1,808.37	5.31	2.69	3.33	11.32	3.72	3.26	5.22	3.27	6.4	5.91	1.95
Price/Tangible Book Value High	-3.46	-2.09	-1.39	-3,421.85	12.74	6.52	7.98	18.02	6.41	6.08	13.61	6.46	9.66	9.34	2.61
Price/Tangible Book Value Low	-1.54	-0.3	-0.37	-376.4	3.14	1.42	1.58	5.13	1.11	1.39	0.97	1.55	3.92	3.16	1.36
Price/Sales	15.65	1.32	3.09	7.25	89.16	186.47	788.46	113.19	- -	14.55	11.16	17.12	30.6	- -	47.95
Price/Sales Average	21.84	4.12	5.05	33.3	123.36	149.75	472.28	219.09	- -	21.55	47.69	27.47	21.86	- -	51.22
Price/Sales High	28.25	7.91	9.89	63.01	295.88	362.95	1,131.7	348.77	- -	40.22	124.36	54.21	32.99	- -	68.6
Price/Sales Low	12.6	1.15	2.6	6.93	72.97	78.82	223.85	99.24	- -	9.17	8.86	13.01	13.38	- -	35.76
Price/Cash Flow	-3.78	-1.47	6,310.62	-4.16	-8.9	-12.74	-29.13	-8.68	-2.62	-4.15	-0.51	-0.56	-2.89	-4.08	-3.66
Price/Cash Flow Average	-5.28	-4.59	10,315.37	-19.12	-12.31	-10.23	-17.45	-16.79	-3.92	-6.15	-2.18	-0.89	-2.07	-4.18	-3.91
Price/Cash Flow High	-6.83	-8.8	20,194	-36.18	-29.52	-24.79	-41.81	-26.73	-6.74	-11.48	-5.68	-1.76	-3.12	-6.6	-5.23
Price/Cash Flow Low	-3.05	-1.28	5,300.92	-3.98	-7.28	-5.38	-8.27	-7.61	-1.17	-2.62	-0.4	-0.42	-1.27	-2.24	-2.73
Price/Free Cash Flow Average	-5.28	-4.59	10,409.36	-19.12	-12.31	-10.23	-17.45	-22.76	-3.93	-6.15	-2.18	-0.89	-2.07	-4.18	-4.88
Price/Free Cash Flow High	-6.83	-8.8	20,378	-36.18	-29.52	-24.79	-41.81	-36.23	-6.76	-11.48	-5.68	-1.76	-3.12	-6.6	-6.53
Price/Free Cash Flow Low	-3.05	-1.28	5,349.22	-3.98	-7.28	-5.38	-8.27	-10.31	-1.17	-2.62	-0.4	-0.42	-1.27	-2.24	-3.41
EV/Sales Average	26.27	4.13	4.94	334.43	111.61	98.58	367.27	218.09	- -	21.97	63.46	57.25	24.52	- -	44.05
EV/Sales High	33.93	8	9.87	639.68	316.29	349.67	1,109.86	348.91	- -	41.33	178.12	117.52	38.33	- -	62.12
EV/Sales Low	15.23	1.09	2.44	63.51	51.83	15.05	87.51	97.19	- -	9.13	5.4	24.66	14	- -	27.98
EV/EBITDA Average	-6.32	-4.66	-2.65	-99.15	-6.45	-3.8	-11.35	-11.72	-4.2	-5.12	-3.6	-1.99	-1.91	-4.24	-2.99
EV/EBITDA High	-8.16	-9.04	-5.3	-189.65	-18.28	-13.48	-34.29	-18.74	-8.51	-9.63	-10.1	-4.08	-2.98	-6.7	-4.21
EV/EBITDA Low	-3.66	-1.23	-1.31	-18.83	-3	-0.58	-2.7	-5.22	-0.01	-2.13	-0.31	-0.86	-1.09	-2.27	-1.9
EV/EBIT Average	-6.13	-4.21	-2.65	-98.8	-6.26	-3.67	-11.04	-11.24	-3.73	-4.53	-3.32	-1.79	-1.78	-4.05	-2.87
EV/EBIT High	-7.92	-8.16	-5.3	-188.98	-17.74	-13.02	-33.37	-17.98	-7.55	-8.52	-9.31	-3.67	-2.78	-6.4	-4.04
EV/EBIT Low	-3.56	-1.11	-1.31	-18.76	-2.91	-0.56	-2.63	-5.01	-0.01	-1.88	-0.28	-0.77	-1.02	-2.16	-1.82
Last Price	1,800	300	312.5	86.25	84	121.25	396.25	178.5	81.75	39.25	8.5	3.08	5.01	5.57	5.27
High Price	3,250	1,800	1,000	750	278.75	236	568.75	550	210.25	108.5	94.75	9.75	5.4	9.01	7.54
Enterprise Value Average	48	18	10	309	116	88	307	654	287	220	190	81	86	260	256
Enterprise Value High	62	35	20	592	329	311	929	1,046	582	413	534	166	134	411	362
Enterprise Value Low	28	5	5	59	54	13	73	291	1	91	16	35	49	139	163

Shares Outstanding	- -	- -	- -	1	1	2	2	2	3	4	6	18	27	46	55
Diluted Weighted Avg Shares	- -	- -	- -	- -	1	1	2	2	2	4	4	8	21	41	66
Basic Weighted Avg Shares	- -	- -	- -	- -	1	1	2	2	2	4	4	8	21	41	53
Revenue per Share	115.04	227.68	101.12	11.9	0.94	0.65	0.5	1.58	- -	2.7	0.76	0.18	0.16	- -	0.11
EBITDA per Share	-478.11	-201.47	-188.22	-40.15	-16.3	-16.86	-16.27	-29.35	-33.97	-11.57	-13.44	-5.17	-2.1	-1.49	-1.62
Operating Income per Share	-492.68	-223.13	-188.37	-40.29	-16.8	-17.47	-16.71	-30.6	-38.27	-13.09	-14.57	-5.76	-2.25	-1.56	-1.69
Basic EPS, GAAP	-269.36	-647.83	76.8	-381.56	-13.16	-16	-16.4	-29.81	-37.87	-22.73	-21.57	-5.53	-2.53	-1.55	1.34
Basic EPS from Cont Ops	-158.39	-544.49	220.31	-344.56	-13.16	-16	-16.4	-29.81	-37.87	-22.73	-21.57	-5.05	-2.53	-1.55	1.34
Diluted EPS, GAAP	-269.36	-647.83	76.11	-381.56	-13.16	-16	-16.4	-29.81	-37.87	-22.73	-21.57	-5.53	-2.53	-1.55	1.08
Diluted EPS from Cont Ops	-158.39	-544.49	218.32	-344.56	-13.16	-16	-16.4	-29.81	-37.87	-22.73	-21.57	-5.05	-2.53	-1.55	1.08
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-475.98	-204.47	0.05	-20.73	-9.44	-9.52	-13.6	-20.57	-31.19	-9.45	-16.68	-5.53	-1.73	-1.36	-1.44
Free Cash Flow per Basic Share	-475.98	-204.47	0.05	-20.73	-9.44	-9.52	-13.6	-25.96	-31.29	-9.45	-16.68	-5.53	-1.73	-1.36	-1.44
Cash & Equivalents per Share	128.71	20.02	20.6	14.43	30.65	42.94	73.45	44.31	38.64	24.71	7.65	2.94	1.97	2.14	3.48
Book Value per Share	-921.2	-863.08	-718.02	6.03	51.71	61.54	90.69	69.9	53.34	26.67	7.2	1.51	0.56	0.96	2.89
Tangible Book Value per Share	-940.14	-863.08	-718.02	-0.22	21.87	36.17	71.26	30.52	32.82	17.84	6.96	1.51	0.56	0.96	2.89

Abeona Therapeutics Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)